| |
 |
|
Class Information
Number: 514/382
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > Tetrazoles (including hydrogenated) > Additional chalcogen containing hetero ring
Description: Subject matter which contains an additional chalcogen containing hetero ring.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7625933 |
Indoles having anti-diabetic activity |
Dec. 1, 2009 |
| 7601747 |
One-pot process for making di-functional di-tetrazole diols to produce tetrazole based polymers |
Oct. 13, 2009 |
| 7576112 |
Therapeutic N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives |
Aug. 18, 2009 |
| 7550448 |
Therapeutic compounds |
Jun. 23, 2009 |
| 7547685 |
Therapeutic substituted pyrrolidone compounds |
Jun. 16, 2009 |
| 7524872 |
Method and composition for treating cancer using cellular organelle crystallizing agents |
Apr. 28, 2009 |
| 7507754 |
EP.sub.4 receptor antagonists |
Mar. 24, 2009 |
| 7468360 |
Therapeutic amides and related compounds |
Dec. 23, 2008 |
| 7414071 |
Methods of treatment with selective EP4 receptor agonists |
Aug. 19, 2008 |
| 7361672 |
Heteroarylacetamide inhibitors of factor Xa |
Apr. 22, 2008 |
| 7314885 |
Pyrrole compounds useful as kinase inhibitors |
Jan. 1, 2008 |
| 7309721 |
Aminoalkylphosphonates and related compounds as Edg receptor agonists |
Dec. 18, 2007 |
| 7307096 |
Combined agents for treatment of glaucoma |
Dec. 11, 2007 |
| 7291623 |
Compounds that interact with kinases |
Nov. 6, 2007 |
| 7291639 |
Aryloxy-acetic acid compounds useful as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
Nov. 6, 2007 |
| 7271187 |
Compositions and methods for promoting tissue regeneration |
Sep. 18, 2007 |
| 7217706 |
Propanolamine derivatives |
May. 15, 2007 |
| 7196089 |
EP.sub.4 receptor antagonists |
Mar. 27, 2007 |
| 7163954 |
Substituted naphthyl benzothiophene acids |
Jan. 16, 2007 |
| 7148248 |
Method of treating or inhibiting the development of brain inflammation and sepsis |
Dec. 12, 2006 |
| 7115658 |
Inhibitors of hepatitis C virus RNA-dependent RNA polymerase |
Oct. 3, 2006 |
| 7109223 |
Oxazolidin-2-one and thiazolidin-2-one derivatives for use as EP.sub.4 receptor agonists in the treatment of glaucoma |
Sep. 19, 2006 |
| 7087553 |
Soil fumigant, herbicide, larvacide, ovacide and fungicide |
Aug. 8, 2006 |
| 7078424 |
N-linked sulfonamides of N-heterocyclic carboxylic acids or carboxylic acid isosteres |
Jul. 18, 2006 |
| 6972292 |
Certain substituted polyketides, pharmaceutical compositions containing them and their use in treating tumors |
Dec. 6, 2005 |
| 6972298 |
Method of treating or inhibiting neutrophil chemotaxis by administering a MEK inhibitor |
Dec. 6, 2005 |
| 6951869 |
Use of leukotriene receptor antagonist for treatment of scarring |
Oct. 4, 2005 |
| 6916831 |
Flavone acetic acid analogs and methods of use thereof |
Jul. 12, 2005 |
| 6906085 |
Tetrahydropyran derivatives as neurokinin receptor antagonists |
Jun. 14, 2005 |
| 6900234 |
Synergistic therapeutic compositions and methods |
May. 31, 2005 |
| 6890928 |
Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
May. 10, 2005 |
| 6864272 |
Method and composition for treating cancer using cellular organelle crystallizing agents |
Mar. 8, 2005 |
| 6756378 |
VLA-4 inhibitor compounds |
Jun. 29, 2004 |
| 6723742 |
Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
Apr. 20, 2004 |
| 6716875 |
Synergistic therapeutic compositions of ACE and renin inhibitors and methods |
Apr. 6, 2004 |
| 6699894 |
Methods for treatment of inflammatory bowel disease |
Mar. 2, 2004 |
| 6699860 |
Di-substituted aminomethyl-chroman derivative beta-3 adrenoreceptor agonists |
Mar. 2, 2004 |
| 6689794 |
Aromatic sulfone hydroxamates and their use as protease inhibitors |
Feb. 10, 2004 |
| 6680319 |
Isoxazolecarboxamide derivatives |
Jan. 20, 2004 |
| 6670394 |
Method for treating COPD |
Dec. 30, 2003 |
| 6620826 |
Endothelin receptor antagonists |
Sep. 16, 2003 |
| 6605641 |
20-HETE antagonists and agonists |
Aug. 12, 2003 |
| 6599925 |
Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1) |
Jul. 29, 2003 |
| 6596769 |
20-Hete antagonists and agonists |
Jul. 22, 2003 |
| 6596750 |
Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
Jul. 22, 2003 |
| 6589970 |
6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
Jul. 8, 2003 |
| 6586462 |
.omega.-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
Jul. 1, 2003 |
| 6555559 |
5,6,7-trinor-4,8-inter-m-phenylene PGI2, derivative and drugs containing the same |
Apr. 29, 2003 |
| 6538022 |
Compounds for deactivating phospholamban function on Ca-ATPase (phopholamban inhibitors) |
Mar. 25, 2003 |
| 6525086 |
Compounds, their preparation and use |
Feb. 25, 2003 |
|
|
|
